DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Bar-Or A, Calabresi PA, Arnold D. et al.
Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial.
Ann Neurol 2008; 63: 395-400
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.